Search Browse Earnings

Stoke Therapeutics, Inc.

Nasdaq:STOK

Pharmaceutical Preparations·BEDFORD, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Stoke Therapeutics, Inc. — SlamSEC

Revenue

$36.6M

+316.3% YoY

FY 2025

Adj. EBITDA

-$99.2M

-271.4% margin

FY 2025

Net Income

-$89.0M

-243.4% margin

FY 2025

EPS (Diluted)

-$1.65

FY 2025

Stock Price

$33.51

+1.0%

2026-03-20

52W Range

$5.35 – $40.22

P/E Ratio

-20.3x

Market Cap

$2.0B

Cash

$128.0M

FY 2025

Total Debt

—

Net Cash

$128.0M

FY 2025

Enterprise Value

$1.9B

Debt / EBITDA

1.3x

FY 2025

EV / EBITDA

-18.7x

Employees

—